JP2023089191A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2023089191A5 JP2023089191A5 JP2023067121A JP2023067121A JP2023089191A5 JP 2023089191 A5 JP2023089191 A5 JP 2023089191A5 JP 2023067121 A JP2023067121 A JP 2023067121A JP 2023067121 A JP2023067121 A JP 2023067121A JP 2023089191 A5 JP2023089191 A5 JP 2023089191A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- seq
- antibody
- fragment
- light chain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18151726.9 | 2018-01-15 | ||
| EP18151726 | 2018-01-15 | ||
| PCT/NL2019/050018 WO2019139481A1 (en) | 2018-01-15 | 2019-01-15 | Factor h potentiating antibodies and uses thereof |
| JP2020538984A JP7471224B2 (ja) | 2018-01-15 | 2019-01-15 | H因子増強抗体及びその使用 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020538984A Division JP7471224B2 (ja) | 2018-01-15 | 2019-01-15 | H因子増強抗体及びその使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023089191A JP2023089191A (ja) | 2023-06-27 |
| JP2023089191A5 true JP2023089191A5 (cg-RX-API-DMAC7.html) | 2023-12-08 |
Family
ID=60972152
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020538984A Active JP7471224B2 (ja) | 2018-01-15 | 2019-01-15 | H因子増強抗体及びその使用 |
| JP2023067121A Pending JP2023089191A (ja) | 2018-01-15 | 2023-04-17 | H因子増強抗体及びその使用 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020538984A Active JP7471224B2 (ja) | 2018-01-15 | 2019-01-15 | H因子増強抗体及びその使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US11377487B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3740502A1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7471224B2 (cg-RX-API-DMAC7.html) |
| KR (2) | KR20250171487A (cg-RX-API-DMAC7.html) |
| CN (1) | CN111868083B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2019206207B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112020014399A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3088507A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL276008A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2020007555A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2019139481A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2019206207B2 (en) * | 2018-01-15 | 2025-04-10 | Stichting Sanquin Bloedvoorziening | Factor H potentiating antibodies and uses thereof |
| JP7631296B2 (ja) * | 2019-07-17 | 2025-02-18 | ジェミニ・セラピューティクス・サブ・インコーポレイテッド | H因子増強性抗体及びその使用 |
| KR20230113578A (ko) * | 2020-11-27 | 2023-07-31 | 선샤인 레이크 파르마 컴퍼니 리미티드 | Cldn18.2 항체 및 그의 용도 |
| KR20240040098A (ko) * | 2021-07-30 | 2024-03-27 | 알.피.쉐러 테크놀러지즈 엘엘씨 | 넥틴-4에 특이적인 항체 및 항체 접합체 및 이의 사용방법 |
| CN116355860A (zh) * | 2021-12-28 | 2023-06-30 | 四川远大蜀阳药业有限责任公司 | 分泌抗h因子抗体的杂交瘤细胞株、抗h因子抗体及其应用 |
| CN116655792B (zh) * | 2022-03-21 | 2024-01-02 | 南京蓬勃生物科技有限公司 | 靶向Siglec-15的单克隆抗体及其应用 |
| NL2032398B1 (en) * | 2022-07-06 | 2024-01-23 | Academisch Ziekenhuis Leiden | Bispecific antibody and uses thereof |
| CN118878671B (zh) * | 2024-07-04 | 2025-09-30 | 南京农业大学 | 抗兽疫链球菌SzM蛋白的猪源化单克隆抗体 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8580714B2 (en) | 2009-10-14 | 2013-11-12 | Janssen Biotech, Inc. | Methods of affinity maturing antibodies |
| CA2780221A1 (en) | 2009-11-04 | 2011-05-12 | Fabrus Llc | Methods for affinity maturation-based antibody optimization |
| AU2015304079B2 (en) | 2014-08-20 | 2021-05-13 | Stichting Sanquin Bloedvoorziening | Factor H potentiating antibodies and uses thereof |
| KR102485788B1 (ko) | 2014-08-27 | 2023-01-09 | 메모리얼 슬로안 케터링 캔서 센터 | 항체, 조성물 및 용도 |
| AU2019206207B2 (en) * | 2018-01-15 | 2025-04-10 | Stichting Sanquin Bloedvoorziening | Factor H potentiating antibodies and uses thereof |
| JP7631296B2 (ja) * | 2019-07-17 | 2025-02-18 | ジェミニ・セラピューティクス・サブ・インコーポレイテッド | H因子増強性抗体及びその使用 |
-
2019
- 2019-01-15 AU AU2019206207A patent/AU2019206207B2/en active Active
- 2019-01-15 CA CA3088507A patent/CA3088507A1/en active Pending
- 2019-01-15 US US16/961,737 patent/US11377487B2/en active Active
- 2019-01-15 KR KR1020257040314A patent/KR20250171487A/ko active Pending
- 2019-01-15 MX MX2020007555A patent/MX2020007555A/es unknown
- 2019-01-15 BR BR112020014399-5A patent/BR112020014399A2/pt unknown
- 2019-01-15 EP EP19714825.7A patent/EP3740502A1/en active Pending
- 2019-01-15 KR KR1020207023681A patent/KR102896085B1/ko active Active
- 2019-01-15 CN CN201980019128.3A patent/CN111868083B/zh active Active
- 2019-01-15 JP JP2020538984A patent/JP7471224B2/ja active Active
- 2019-01-15 WO PCT/NL2019/050018 patent/WO2019139481A1/en not_active Ceased
-
2020
- 2020-07-13 IL IL276008A patent/IL276008A/en unknown
-
2022
- 2022-06-01 US US17/829,688 patent/US12624094B2/en active Active
-
2023
- 2023-04-17 JP JP2023067121A patent/JP2023089191A/ja active Pending